Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exponent (EXPO) Cash from Financing Activities: 2010-2025

Historic Cash from Financing Activities for Exponent (EXPO) over the last 13 years, with Oct 2025 value amounting to -$54.5 million.

  • Exponent's Cash from Financing Activities fell 320.61% to -$54.5 million in Q4 2025 from the same period last year, while for Oct 2025 it was -$134.3 million, marking a year-over-year decrease of 84.48%. This contributed to the annual value of -$65.1 million for FY2025, which is 24.30% up from last year.
  • As of Q4 2025, Exponent's Cash from Financing Activities stood at -$54.5 million, which was down 14.83% from -$47.5 million recorded in Q3 2025.
  • In the past 5 years, Exponent's Cash from Financing Activities ranged from a high of -$8.8 million in Q4 2021 and a low of -$75.1 million during Q3 2022.
  • For the 3-year period, Exponent's Cash from Financing Activities averaged around -$24.8 million, with its median value being -$20.0 million (2025).
  • Per our database at Business Quant, Exponent's Cash from Financing Activities plummeted by 379.19% in 2022 and then surged by 83.16% in 2023.
  • Exponent's Cash from Financing Activities (Quarterly) stood at -$10.0 million in 2021, then crashed by 154.54% to -$25.4 million in 2022, then rose by 21.18% to -$20.0 million in 2023, then skyrocketed by 56.19% to -$13.0 million in 2024, then crashed by 320.61% to -$54.5 million in 2025.
  • Its Cash from Financing Activities stands at -$54.5 million for Q4 2025, versus -$47.5 million for Q3 2025 and -$20.0 million for Q2 2025.